2-amino-5-(4-cyclopropyl-6,6-dimethyl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyridine-3-carbonitrile
C19H19N7O — CID 122517556
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-amino-5-(4-cyclopropyl-6,6-dimethyl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyridine-3-carbonitrile
2-amino-5-(4-cyclopropyl-6,6-dimethyl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyridine-3-carbonitrile (PubChem CID 122517556) has the molecular formula C19H19N7O and a molecular weight of 361.41 g/mol. Its IUPAC name is 2-amino-5-(4-cyclopropyl-6,6-dimethyl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 2-amino-5-(4-cyclopropyl-6,6-dimethyl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 122517556 |
| Molecular Formula | C19H19N7O |
| Molecular Weight | 361.41 g/mol |
| Exact Mass | 361.17 |
| IUPAC Name | 2-amino-5-(4-cyclopropyl-6,6-dimethyl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyridine-3-carbonitrile |
| SMILES | CC1(C)OCCn2c1nc1c(C3CC3)nc(-c3cnc(N)c(C#N)c3)nc12 |
| InChI | InChI=1S/C19H19N7O/c1-19(2)18-24-14-13(10-3-4-10)23-16(25-17(14)26(18)5-6-27-19)12-7-11(8-20)15(21)22-9-12/h7,9-10H,3-6H2,1-2H3,(H2,21,22) |
| InChIKey | LZIDZKAPYXYGJI-UHFFFAOYSA-N |
| XLogP | 2.48 |
| TPSA | 115.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 361.41 |
| LogP ≤ 5 | 2.48 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122517556 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.